MESO failed because their trial endpoint was 43% reduction in mortality at 30 days. This is very hard to prove now. If you read their PR it goes into detail.
Yes, I believe there is. And it is this fact that needs to be known and considered. There are very astute people here. I would like them to look into this, and share what they discover, if they don't already know the answer. I think it would mean more coming from somebody other than me, because many may suspect me to be biased, although I try not to be.
News 
Market Data 
Discover 
AI
